ABBV - AbbVie sees maintaining Botox position in aesthetics: report
2024-01-10 16:46:06 ET
More on AbbVie
- AbbVie Inc. (ABBV) J.P. Morgan 42nd Annual Healthcare Conference
- AbbVie: Still Expensive Despite The Great M&A Acumen
- Investor's Dilemma: AbbVie Stock Amidst U.S. Election And Humira Decline
- AbbVie announces EU availability of Parkinson's therapy
- AbbVie advancing hidradenitis suppurative drug to Phase 3
For further details see:
AbbVie sees maintaining Botox position in aesthetics: report